# US 2026/0091175 A1 · Drug delivery system with graphical user interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0091175 A1
- Document ID: US20260091175A1
- Status: Published application
- Kind: A1
- Application number: 19/110,804
- Filed: 2022-09-13
- Published: 2026-04-02
- Earliest claimed: 2022-09-13
- Assignees: Medtrum Technologies Inc.
- Applicants: Medtrum Technologies Inc.
- Inventors: Cuijun Yang
- Web page: https://patentgrep.com/patent/US20260091175A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- G16H 20/17: delivered via infusion or injection
- G16H 40/40: for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
- G16H 40/63: for local operation
- G16H 40/67: for remote operation
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61M 2205/18: with alarm
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/584: having a color code
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The invention discloses a drug delivery system with graphical user interface comprises a detection device, for detecting the blood glucose level of the user; an infusion device, for infusing a drug into the user's body; and a control device, wirelessly communicated with the detection device and the infusion device, the control device controlling the drug delivery of the infusion device, and the control device provided with a graphical user interface, the graphical user interface comprising a main screen, the main screen comprising an insulin information display area and a blood glucose information display area, wherein the insulin information display area comprising insulin infusion status information, the graphical user interface displays the insulin infusion status information in a graphical and/or textual manner, to facilitate the user to intuitively know the insulin infusion status information and blood glucose information at that time.

## Claims

### Claim 1

A drug delivery system with graphical user interface, comprising:
a detection device, for detecting a blood glucose level of a user;
an infusion device, for infusing a drug into the user's body; and
a control device, wirelessly communicated with the detection device and the infusion device, the control device controlling a drug delivery of the infusion device, and the control device provided with a graphical user interface, the graphical user interface comprising a main screen, the main screen comprising an insulin information display area and a blood glucose information display area, the insulin information display area comprising insulin infusion status information, the graphical user interface displays the insulin infusion status information in a manner of a graphic and/or a text.

### Claim 2 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the graphic is a ring with at least one color indicating an infusion type and a progress of the insulin infusion, the text comprising an abbreviation of the infusion type and a rate or a progress of the infusion type.

### Claim 3 (depends on 2)

The drug delivery system with graphical user interface of claim 2, wherein the blood glucose information display area comprises a blood glucose graphic display area and the detection device status display area.

### Claim 4 (depends on 3)

The drug delivery system with graphical user interface of claim 3, wherein the detection device status display area is set inside the ring.

### Claim 5 (depends on 4)

The drug delivery system with graphical user interface of claim 4, wherein the detection device status display area displays information that the detection device is in a general detection state or a special detection state.

### Claim 6 (depends on 5)

The drug delivery system with graphical user interface of claim 5, wherein when the detection device is in the general detection state, the detection device status display area shows a blood glucose reading of a latest moment.

### Claim 7 (depends on 5)

The drug delivery system with graphical user interface of claim 5, wherein when the detection device is in the special detection state, the detection device status display area shows a text message with a specific meaning to alert the user that an abnormal blood glucose value was detected by the detection device or there is an abnormal in the detection device.

### Claim 8 (depends on 3)

The drug delivery system with graphical user interface of claim 3, wherein the blood glucose graphic display area comprises a blood glucose reading curve or blood glucose reading discrete points over a period of time, and a normal blood glucose value area or standardized lines for high blood glucose values and low blood glucose values.

### Claim 9 (depends on 6)

The drug delivery system with graphical user interface of claim 6, wherein when the detection device is in the general detection state, the detection device status display area further comprises a blood glucose trend display area.

### Claim 10 (depends on 9)

The drug delivery system with graphical user interface of claim 9, wherein the blood glucose trend display area is indicated by indicator arrows with different color, direction and number.

### Claim 11 (depends on 10)

The drug delivery system with graphical user interface of claim 10, wherein the blood glucose trend display area is set in the ring.

### Claim 12 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the main screen further comprises a calibration display area of the detection device.

### Claim 13 (depends on 12)

The drug delivery system with graphical user interface of claim 12, wherein the calibration display area dynamically displays a calibration status of the detection device over time.

### Claim 14 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the main screen further comprises a blood glucose data recovery icon, the blood glucose data recovery icon appears during a blood glucose data recovery and disappears when blood glucose data is fully recovered.

### Claim 15 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the main screen further comprises a suspend infusion function icon, for displaying a state of hypoglycemia suspend infusion function or a predicted hypoglycemia suspend infusion function in the drug delivery system.

### Claim 16

The drug delivery system with graphical user interface of claim wherein the main screen further comprises an alert status icon.

### Claim 17 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the detection device and the infusion device are provided in separate components.

### Claim 18 (depends on 1)

The drug delivery system with graphical user interface of claim 1, wherein the detection device and the infusion device are provided in the same component.

### Claim at position 19

19-72. (canceled)
